Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors

Biotechnology and Bioengineering

Volumn 113, Issue 1, 2016, Pages 226-236

  Cerino, Giulia ^a   Gaudiello, Emanuele ^a   Grussenmeyer, Thomas ^a   Melly, Ludovic ^a   Massai, Diana ^b   Banfi, Andrea ^a   Martin, Ivan ^a   Eckstein, Friedrich ^a   Grapow, Martin ^a   Marsano, Anna ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b POLITECNICO DI TORINO   (Italy)

Author keywords

Bioreactor; Perfusion; Serum percentage; Skeletal myoblasts; Stromal cells; Tissue engineering

Indexed keywords

BIOCONVERSION; BIOREACTORS; BODY FLUIDS; CELL CULTURE; CELLS; CYTOLOGY; ENDOTHELIAL CELLS; HISTOLOGY; MONOLAYERS; MUSCLE; MUSCULOSKELETAL SYSTEM; OXYGEN SUPPLY; TISSUE; TISSUE ENGINEERING;

BIOREACTOR CULTURES; CELLULAR ENVIRONMENT; MYOBLAST PROLIFERATION; PERFUSION; SERUM PERCENTAGE; SKELETAL MYOBLASTS; STROMAL CELLS; THREEDIMENSIONAL (3-D);

CELL ENGINEERING;

CULTURE MEDIUM; OXYGEN;

ANIMAL; BIOREACTOR; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; CULTURE MEDIUM; METABOLISM; PHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE CELL; SKELETAL MYOBLAST; STROMA CELL; TISSUE ENGINEERING;

ANIMALS; BIOREACTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MYOBLASTS, SKELETAL; OXYGEN; STROMAL CELLS; TISSUE ENGINEERING;

EID: 84947996834     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25688     Document Type: Article

References (44)

1. Baffour R, Pakala R, Hellinga D, Joner M, Okubagzi P, Epstein SE, Waksman R. 2006. Bone marrow-derived stem cell interactions with adult cardiomyocytes and skeletal myoblasts in vitro. Cardiovasc Revasc Med 7(4):222-230.
2. Bajaj P, Reddy B, Jr, Millet L, Wei C, Zorlutuna P, Bao G, Bashir R. 2011. Patterning the differentiation of C2C12 skeletal myoblasts. Integr Biol 3(9):897-909.
3. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SG, Miller SC, Webster C. 1985. Plasticity of the differentiated state. Science 230(4727):758-766.
4. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. 2013. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15(6):641-648.
5. Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, Vunjak-Novakovic G. 1999. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64(5):580-589.
6. Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G. 2002a. Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng 78(6):617-625.
7. Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G. 2002b. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng 8(2):175-188.
8. Cheng CS, El-Abd Y, Bui K, Hyun YE, Hughes RH, Kraus WE, Truskey GA. 2014. Conditions that promote primary human skeletal myoblast culture and muscle differentiation in vitro. Am J Physiol Cell Physiol 306(4):C385-C395.
9. Chowdhury SR1, Muneyuki Y, Takezawa Y, Kino-oka M, Saito A, Sawa Y, Taya M. 2010. Growth and differentiation potentials in confluent state of culture of human skeletal muscle myoblasts. J Biosci Bioeng 109(3):310-313.
10. Dugan JM, Cartmell SH, Gough JE. 2014. Uniaxial cyclic strain of human adipose-derived mesenchymal stem cells and C2C12 myoblasts in coculture. J Tissue Eng 27(5).
11. Elliott NT, Yuan F. 2011. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 100(1):59-74.
12. Egusa H, Kobayashi M, Matsumoto T, Sasaki J, Uraguchi S, Yatani H. 2013. Application of cyclic strain for accelerated skeletal myogenic differentiation of mouse bone marrow-derived mesenchymal stromal cells with cell alignment. Tissue Eng Part A 19(5-6):770-782.
13. Goto S, Miyazaki K, Funabiki T, Yasumitsu H. 1999. Serum-free culture conditions for analysis of secretory proteinases during myogenic differentiation of mouse C2C12 myoblasts. Anal Biochem 272(2):135-142.
14. Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwörer A, Uebeler J, Eschenhagen T. 2010. Development of a drug screening platform based on engineered heart. Circ Res 107(1):35-44.
15. Huang YC, Dennis RG, Larkin L, Baar K. 2005. Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol 98(2):706-713.
16. Jang Y, Koh YG, Choi YJ, Kim SH, Yoon DS, Lee M, Lee JW. 2015. Characterization of adipose tissue-derived stromal vascular fraction for clinical application to cartilage regeneration. In Vitro Cell Dev Biol Anim 51(2):142-150.
17. Juhasa M, Engelmayr GC, Jr., Fontanella AN, Palmerb GM, Bursac N. 2014. Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. PNAS 111(15):5508-5513.
18. Kaspar P, Pajer P, Sedlak D, Tamaoki T, Dvorak M. 2005. C-Myb inhibits myogenic differentiation through repression of MyoD. Exp Cell Res 309:419-428.
19. Kroehne V, Heschel I, Schügner F, Lasrich D, Bartsch JW, Jockusch H. 2008. Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med 12(5A):1640-1648.
20. Lassar AB, Skapek SX, Novitch B. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 6:788-794.
21. Lawson MA, Purslow PP. 2000. Differentiation of myoblasts in serum-free media: Effects of modified media are cell line-specific. Cells Tissues Organs 167(2-3):130-137.
22. Lindon C, Albagli O, Pinset C, Montarras D. 2001. Cell density-dependent induction of endogenous myogenin (myf4) gene expression by Myf5. Dev Biol 240(2):574-584.
23. Ma J, Holden K, Zhu J, Pan H, Li Y. 2011. The application of three-dimensional collagen-scaffolds seeded with myoblasts to repair skeletal muscle defects. J Biomed Biotechnol 2011.
24. Maidhof R, Marsano A, Lee EJ, Vunjak-Novakovic G. 2010. Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnol Prog 26(2):565-572.
25. Martin I, Smith T, Wendt D. 2009. Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnol 27(9):495-502.
26. Massai D, Cerino G, Gallo D, Pennella F, Deriu MA, Rodriguez A, Montevecchi FM, Bignardi C, Audenino A, Morbiducci U. 2013. Bioreactors as engineering support to treat cardiac muscle and vascular disease. J Healthc Eng 4(3):329-370.
27. Portiér GL, Benders AG, Oosterhof A, Veerkamp JH, van Kuppevelt TH. 1999. Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cell Dev Biol 35(4):219-227.
28. Radisic M, Euloth M, Yang L, Langer R, Freed LE, Vunjak-Novakovic G. 2003. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng 82(4):403-414.
29. Radisic M, Yang L, Boublik J, Cohen RJ, Langer R, Freed LE, Vunjak-Novakovic G. 2004. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 286(2):H507-H516.
30. Radisic M, Marsano A, Maidhof R, Wang Y, Vunjak-Novakovic G. 2008. Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc 3(4):719-738.
31. Rahbarghazi R, Nassiri SM, Khazraiinia P, Kajbafzadeh AM, Ahmadi SH, Mohammadi E, Molazem M, Zamani-Ahmadmahmudi M. 2013. Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics. Stem Cells Dev 22(6):855-865.
32. Rando TA, Blau HM. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125:1275-1287.
33. Rao N, Evans S, Stewart D, Spencer KH, Sheikh F, Hui EE, Christman KL. 2013. Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices. Biomed Microdevices 15(1):161-169.
34. Sadr N, Pippenger BE, Scherberich A, Wendt D, Mantero S, Martin I, Papadimitropoulos A. 2012. Enhancing the biological performance of synthetic polymeric materials by decoration with engineered, decellularized extracellular matrix. Biomaterials 33(20):5085-5093.
35. Sassoli C, Pini A, Chellini F, Mazzanti B, Nistri S, Nosi D, Saccardi R, Quercioli F, Zecchi-Orlandini S, Formigli L. 2012. Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS ONE 7(7).
36. Scherberich A, Galli R, Jaquiery C, Farhadi J, Martin I. 2007. Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells 25(7):1823-1829.
37. Sharples AP, Player DJ, Martin NR, Mudera V, Stewart CE, Lewis MP. 2012. Modelling in vivo skeletal muscle ageing in vitro using three-dimensional bioengineered constructs. Aging Cell 11(6):986-995.
38. Siepe M, Giraud MN, Liljensten E, Nydegger U, Menasché P, Carrel T, Tevaearai HT. 2007. Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair. Artif Organs 31(6):425-433.
39. Sun Y, Ge Y, Drnevich J, Zhao Y, Band M, Chen J. 2010. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J Cell Biol 189(7):1157-1169.
40. Tanaka K, Sato K, Yoshida T, Fukuda T, Hanamura K, Kojima N, Shirao T, Yanagawa T, Watanabe H. 2011. Evidence for cell density affecting C2C12 myogenesis: Possible regulation of myogenesis by cell-cell communication. Muscle Nerve 44(6):968-977.
41. Wendt D, Marsano A, Jakob M, Heberer M, Martin I. 2003. Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng 84(2):205-214.
42. Yaffe D, Saxel O. 1977. A myogenic cell line with altered serum requirements for differentiation. Differentiation 7(3):159-166.
43. Yoshiko Y, Hirao K, Maeda N. 2002. Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion. Am J Physiol 283:C1273.
44. Zimmermann WH, Schneiderbanger K, Schubert P, Didié M, Münzel F, Heubach JF, Kostin S, Neuhuber WL, E schenhagen T. 2002. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90(2):223-30.